What a fractional CMO actually does: the first 90 days

A CEO I worked with at a Series A B2B SaaS company asked me in week two whether I had started on the content strategy yet. It was a fair question. He was paying for marketing leadership, and the most visible thing marketing leadership produces is content. I told him I had not, and explained what I was doing instead. He was skeptical. By day 45 he told me it was the best $6,000 per month he had ever spent, because the content strategy we built from week six onward was built on something real.

That gap between what founders expect a fractional CMO to do and what a fractional CMO should actually do in the first weeks of an engagement is where most of the failure in this category happens. The sequence is the product.

Three phases. Three different jobs.

The first 90 days of a fractional CMO engagement split into three distinct phases. The most common failure is collapsing all three into one by starting execution in week two.

Days 1 to 30: diagnosis, not onboarding

Onboarding and diagnosis are not the same thing. In weeks one and two, people are showing you the best version of the company. The sales team demos their strongest deck. The CEO shares the pitch that closed the Series A. The marketing team shows the campaigns that performed best. Real diagnosis starts in week three, when the introductions stop and the expectations start.

Before committing to any targets or building any strategy, the diagnostic work addresses three questions:

Who actually bought, versus who the deck says bought. The ICP in the sales deck is a hypothesis. The last fifteen closed deals are data. These are almost never identical. Pulling those deals, mapping who was actually in the buying room, how they found you, and how they compare to the deck produces the first real picture of what the market is telling you. Most CRMs do not capture this cleanly, which is itself a diagnostic signal.

What market type the company is actually competing in. Companies often inherit investor pitch language that frames them as creating a new category, when buyers are actually comparing them to existing alternatives and making a straightforward substitution decision. The four questions that clarify this: does the buyer have vocabulary for the problem before you show up, who do they mention in competitive calls, does the investor pitch match what the sales team says in the field, and what does a win actually look like for the buyer once they have bought. The answer changes the entire marketing motion.

What was inherited and whether it is worth keeping. Every company has prior marketing efforts: a positioning statement someone wrote at Series A, a set of channels someone started, a messaging framework someone built from their last job. Some of it is right. Some is load-bearing but wrong. The job in weeks three and four is to tell the difference before building anything on top of it.

The 30-day presentation is not a report. It is a negotiation for the next 60 days. The goal is to establish the premise for what gets built, not to propose fixes yet.

One thing the book I am writing on this specific topic makes explicit: the founder's desire for pipeline targets by week two is a legitimate position, not a problem to manage. The fractional CMO's job is to earn the exception to that expectation through evidence, not through explaining why diagnosis takes time. If the diagnosis is solid, the conversation changes by week four. If it is not solid, starting campaigns earlier would not have helped.

Days 31 to 60: installation, not campaigns

This is where the diagnosis becomes infrastructure. The ICP criteria produced in the first 30 days get embedded into the sales motion: what a qualified lead actually looks like, how outbound targeting changes, what the revised criteria mean for the SDR's call list. The positioning rewrite, informed by what buyers actually said and what market type the company is competing in, gets produced and tested with the sales team before it goes anywhere public.

Channel selection happens here, based on where the ICP actually is and what the company can realistically resource with its current team. This is not a brainstorming exercise. It is a constraint exercise. Most early-stage B2B companies can run two or three channels well. Trying to run six means running six things poorly.

This phase also almost always surfaces something unexpected: a shadow marketing function that existed before the engagement. A social media agency hired by the founder eighteen months ago and never cancelled. A part-time communications contractor someone in sales brought in. A freelance writer producing content nobody told the fractional CMO about. Integrating or ending those arrangements is part of the installation work, and it is almost always a political conversation.

The Founder's Marketing Workbook has tools specifically for the ICP definition and positioning exercises this phase produces. If you are doing this work ahead of a fractional CMO engagement, those tools give you a head start on what the first 30 days would surface.

Days 61 to 90: defense

The third phase is not about building more things. It is about proving that what was built holds up. The board meeting is almost always in this window. The pressure for pipeline results is at its highest. The work is defending the infrastructure choices made in phase two with the evidence produced in phase one.

The honest outcome of a well-run first 90 days is not a full pipeline. It is a foundation the company can defend. A positioning brief written in buyer language that the sales team will actually use in calls. A measurement framework that surfaces the two or three metrics that would change strategy if they moved in the wrong direction. A channel and content plan built on what buyers actually say, not what the founding team assumed they would say.

Every campaign, every piece of content, and every channel decision built on top of that foundation performs better than whatever came before. Not because the campaigns are smarter. Because the foundation is right.

The way I think about the end of the first engagement: by day 90 a fractional CMO should have earned another 90 days, not a standing ovation. The board should understand what the next 60 days will produce and why. The CEO should feel that the diagnosis was accurate. The sales team should already be using the revised ICP criteria in calls. That is a successful first 90 days.

What this is not

If your current fractional CMO is three weeks in and already running campaigns, ask what those campaigns are built on. The answer tells you whether the engagement is producing a marketing function or just producing marketing activity. The difference shows up in conversion rates, not in volume.

If you want to understand what this looks like in practice at a B2B SaaS company at your stage, a 30-minute call gives you a clear picture of what the first 90 days would actually cover and what it would take to get there.